Ftse Mib
34.061,59
0,95%
DAX
19.932,20
0,47%
S&P 500
5.965,85
-1,19%
NASDAQ
19.608,05
-2,06%
Bitcoin
94.587,49
-1,15%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Repare Therapeutics Inc (RPTX) Repare Therapeutics Inc (RPTX) Notizie

Repare Therapeutics Inc

RPTX
1,28
-0,04 (-3,03%)
Ultimo aggiornamento: 17:13:40
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/12/202422:28EDGAR2Form 8-K - Current report
12/12/202422:20BWRepare Therapeutics Announces Positive Results of the..
10/12/202422:05BWRepare Therapeutics to Host Webcast to Report Data from the..
14/11/202423:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202415:42EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202413:05BWRepare Therapeutics Announces Agreement with the US National..
07/11/202414:33EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/11/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:10EDGAR2Form 8-K - Current report
07/11/202413:05BWRepare Therapeutics Provides Business and Clinical Update..
23/10/202412:05BWRepare Therapeutics Announces Updated Positive Safety and..
14/10/202413:05BWRepare Therapeutics Doses First Patient in Phase 1 Clinical..
30/9/202422:05BWRepare Therapeutics Announces Phase 1 Data Highlighting..
23/9/202413:05BWRepare Therapeutics Announces New Data Underscoring Need for..
13/9/202413:00BWRepare Therapeutics to Present Data from Phase 1/2 TRESR..
28/8/202422:15EDGAR2Form 8-K - Current report
28/8/202422:05BWRepare Therapeutics Announces Strategic Reprioritization to..
27/8/202413:05BWRepare Therapeutics to Participate in Two Upcoming Investor..
20/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
07/8/202415:06EDGAR2Form 8-K - Current report
06/8/202422:41EDGAR2Form S-3 - Registration statement under Securities Act of..
06/8/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:11EDGAR2Form 8-K - Current report
06/8/202422:05BWRepare Therapeutics Provides Business and Clinical Update..
16/7/202415:00PRNCAAlberta Enterprise Corporation invests US$7.5 million into..
26/6/202416:30BWRepare Therapeutics Announces Positive Initial Data at ESMO..
17/6/202422:05EDGAR2Form 8-K - Current report
10/6/202413:05BWRepare Therapeutics Doses First Patient in Camonsertib..
04/6/202422:05BWRepare Therapeutics Announces Fast Track Designation Granted..
03/6/202422:05BWRepare Therapeutics to Participate in the Goldman Sachs 45th..
29/5/202413:05BWRepare Therapeutics to Present Initial Phase 1 MINOTAUR Data..
24/5/202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/5/202416:10APSSmall Cap Massively Bid Following Key Q1 Earnings Beat
07/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:05BWRepare Therapeutics Provides Business and Clinical Update..
30/4/202413:05BWDebiopharm & Repare Therapeutics Announce First Patient..
26/4/202422:05BWRepare Therapeutics Appoints Steven H. Stein, M.D. to its..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202403:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:05BWRepare Therapeutics to Participate in Two Upcoming Investor..
28/2/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202413:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202413:10EDGAR2Form 8-K - Current report
28/2/202413:05BWRepare Therapeutics Provides Business Update and Reports..
15/2/202413:05BWRepare Therapeutics Doses First Patient in Phase 1 Clinical..
15/2/202403:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202422:48EDGAR2Form 8-K - Current report
12/2/202422:05BWRepare Therapeutics to Regain Global Rights to Camonsertib
25/1/202420:29EDGAR2Form 8-K - Current report
Apertura: 1,30 Min: 1,25 Max: 1,32
Chiusura: 1,32

La tua Cronologia

NASDAQ
RPTX
Repare Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network